FDA Inspection
Sinopep-Allsino Biopharmaceutical Co., Ltd.Sinopep-Allsino Biopharmaceutical Co., Ltd. – FDA Inspection, Sep 20, 2024
Record Details
This FDA Inspection record concerns Sinopep-Allsino Biopharmaceutical Co., Ltd., with an inspection on September 20, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- September 20, 2024
- Product Type
- Human Drugs
View Company Profile
ID · de864c97-ff4b-4ae5-9a4f-69acfc670143
Inspection Facts
- Inspection number
- 1254530
- FDA center
- Human Drugs
Other FDA inspections of Sinopep-Allsino Biopharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 18, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 22, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 11, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sinopep-Allsino Biopharmaceutical Co., Ltd.
- FDA Inspection 1080987 - 2019-01-18
- FDA Inspection 969680 - 2016-04-22
- FDA Inspection 883828 - 2014-04-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.